Apr 28 2017 Podcast Courthouse Steps: Amgen, Inc. v. Sandoz, Inc. - Podcast Andrew A. Hufford Intellectual Property Practice Group Podcast The Biologics Price Competition and Innovation Act of 2010 (42 U.S.C. § 262) created an...
Jun 20 2017 Podcast Courthouse Steps: Sandoz Inc. v. Amgen Inc. - Podcast Gregory Dolin, Erika Lietzan Intellectual Property Practice Group Podcast In a decision likely to shape not only future biosimilar litigation but the biosimilar industry...
Aug 11 2017 Podcast Sandoz, Inc. v. Amgen, Inc. Post-Decision SCOTUScast Erika Lietzan SCOTUScast 8-11-17 featuring Erika Lietzan On June 12, 2017, the Supreme Court decided Sandoz, Inc. v. Amgen, Inc. consolidated with...
Apr 18 2024 Topics Federal Courts • Federalism • Intellectual Property Blog Post The Bayh-Dole Act and the Debate Over “Reasonable Price” March-In Rights Andrei Iancu, Cooper Godfrey In 1980, Congress passed the bipartisan Patent and Trademark Law Amendments Act—better known as the...
Courthouse Steps: Amgen, Inc. v. Sandoz, Inc. - Podcast
Andrew A. Hufford
Intellectual Property Practice Group Podcast
The Biologics Price Competition and Innovation Act of 2010 (42 U.S.C. § 262) created an...
Courthouse Steps: Sandoz Inc. v. Amgen Inc. - Podcast
Gregory Dolin, Erika Lietzan
Intellectual Property Practice Group Podcast
In a decision likely to shape not only future biosimilar litigation but the biosimilar industry...
Sandoz, Inc. v. Amgen, Inc. Post-Decision SCOTUScast
Erika Lietzan
SCOTUScast 8-11-17 featuring Erika Lietzan
On June 12, 2017, the Supreme Court decided Sandoz, Inc. v. Amgen, Inc. consolidated with...
Topics
The Bayh-Dole Act and the Debate Over “Reasonable Price” March-In Rights
In 1980, Congress passed the bipartisan Patent and Trademark Law Amendments Act—better known as the...